Sun Pharma shares rise on ₹3,000 crore project approval
after close1 source ↓written by the desknot a recommendation
- after the approval
- 0.59%
- greenfield project
- ₹3,000 crore
- 815.95
- 42,515 shares traded
Sun Pharmaceutical Industries shares increased to ₹1,808.70, up by 0.59% after the approval of a ₹3,000 crore greenfield project by its subsidiary, Sun Pharma Laboratories. The stock reached a session high of ₹1,815.95 with 42,515 shares traded. This investment is expected to enhance production capacity and drive future growth.
Not investment advice. For informational purposes only.